Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance

Overview of attention for article published in Annals of the Rheumatic Diseases, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,996 followers.

RT @AnnemarieVtW: Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases #biologics #immunogenicity http…

RT @AnnemarieVtW: Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases http://t.co/JxRbF0VVlt

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.